Fundamental Data for EVVV

EV3 INC(NSDQ:EVVV)

ev3 Inc. is a global medical device company focused on endovascular technologies for the minimally invasive treatment of vascular diseases and disorders.

# Employees: 1250

Address: 9600 54th Avenue North Suite 100,Plymouth,MN,USA

Phone: 763 398-7000

Fax: 763-398-7200

Website: www.ev3.net

Email: jtracy@ev3.net

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

James M. Corbett (Chmn.; Presi.; C.E.O.)

Patrick D. Spangler (Sr. V.P.; C.F.O.)

Kevin M. Klemz (Sr. V.P.; Sec.; Chief Legal Off.)

Julie D. Tracy (Sr. V.P.; Chief Communications Off.)

Gregory Morrison (Sr. V.P.; Human Resources,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/23/2010

Mean EPS (Next Qtr): $0.12

Mean EPS (Year): $0.22

Mean Estimate(Long Term): $25.67

P/E Ratio(Based on EPS estimate): 57.990

Number of Estimates: 11

Shares Performance

Period	EVVV	Compare to S&P
YTD	106.56 %	70.95 %
4 Weeks	8.15 %	6.99 %
12 Weeks	-1.18 %	-6.83 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1135485

Shares Outstanding: 112M

Market Cap: $1.41B

52 Week High: $12.99

52 Week Low: $3.79

P/E Ratio: 48.460

PEG Ratio: 2.260

Split: On 1/1/1990 EVVV split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 27.27 %

EPS Growth in Last Year: 300.00 %

Sales Growth in Last Quarter: 3.44 %

Sales Growth in Last Quarter: 5.43 %

Financials

Qtr Book Value: $1.92

Cash Flow/Share: $4.52

Change in Payout Ratio: 0.000

Price/Sales: 3.300